| Similar Articles |
|---|
 |
The Motley Fool
November 9, 2006
Jack Uldrich |
Nucryst Still Licking Its Wounds This the medical-products maker with a nanotech bent's sagging fortunes aren't likely to reverse soon. Investors, take note.   |
The Motley Fool
July 20, 2007
Jack Uldrich |
Nucryst's Nanocrystal Coup Nanosys receives FDA clearance on its anti-microbial cream and shares soar. |
The Motley Fool
October 27, 2005
Stephen D. Simpson |
Will Smith & Nephew Keep Flexing? This smaller, British, orthopedic company has competitive products, but industry trends could hurt it. However, the entire orthopedic sector is getting pretty interesting from a value perspective. |
The Motley Fool
July 27, 2006
Stephen D. Simpson |
Smith & Nephew: Better Is Good Enough For British medical device company Smith & Nephew investors, better-than-expected is just fine. |
The Motley Fool
November 6, 2006
Matthew Crews |
Smith & Nephew Is Hip to Growth The medical technology company is showing solid growth, but a possible acquisition is cause for concern. Investors, take note. |
The Motley Fool
January 6, 2006
Jack Uldrich |
2005 Gave Nanotech Investors Plenty to Chew On For investors who have been holding off investing in nanotechnology because they thought there was more "sizzle" than "steak," here are some developments that offer plenty to chew on. |
